Abstract: This invention relates to drug delivery and in particular to the delivery of biologically active agents in the form of dry powders for inhalation. The invention also relates to methods for preparing such dry powder formulations and methods for their use.
Type:
Application
Filed:
November 7, 2011
Publication date:
October 2, 2014
Applicant:
Monash University
Inventors:
Michelle Mcintosh, David Morton, Tomas Sou, Livesey Olerile, Richard Prankerd
Abstract: The present invention relates to imaging of a human or animal heart, particularly imaging of movement of the heart and can be used for imaging function and form in a wide range of research, medical, veterinary and industrial applications. In particular, the present invention provides a method and apparatus for imaging a subject heart, the method including the steps of (1) recording at least one in vivo image of a lung of the subject in one or more regions; (2) applying said at least one in vivo image to a 2D or 3D heart model; and (3) reconstructing a 2D or 3D image field of the subject heart.
Type:
Application
Filed:
October 10, 2012
Publication date:
September 25, 2014
Applicant:
MONASH UNIVERSITY
Inventors:
Andreas Fouras, Stephen Dubsky, Jordan Thurgood
Abstract: The present invention relates generally to affinity ligands and chemical affinity ligand-matrix conjugates for use as chromatographic adsorbents and methods which utilize the adsorbents in the purification of proteins by affinity chromatography. The affinity ligand-matrix conjugates of the present invention comprise ligands of general formula (I): wherein m represents an integer from 0-2, n represents an integer from 0-6, p represents an integer from 0-4, R1 represents H or C1-3 alkyl, R2 is an optional substituent, and X is the position at which the ligand is immobilized, optionally via a linker.
Type:
Grant
Filed:
October 15, 2010
Date of Patent:
June 10, 2014
Assignee:
Monash University
Inventors:
Milton T W Hearn, Anjali Makarand Bhagwat, William Roy Jackson, Simon John Mountford
Abstract: The present invention generally relates to lithium based energy storage devices. According to the present invention there is provided a lithium energy storage device comprising: at least one positive electrode; at least one negative electrode; and an ionic liquid electrolyte comprising an anion, a cation counterion and lithium mobile ions, wherein the anion comprises a nitrogen, boron, phosphorous, arsenic or carbon anionic group having at least one nitrile group coordinated to the nitrogen, boron, phosphorous, arsenic or carbon atom of the anionic group.
Type:
Application
Filed:
October 28, 2013
Publication date:
May 8, 2014
Applicants:
MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Abstract: The present disclosure relates generally to binder powders for use in powder material processing and processes for their preparation. The disclosure further relates to binder powders for use in making solid powder compact forms, solid powder compact forms containing said binder powders and methods for making solid powder compact forms.
Type:
Application
Filed:
February 28, 2012
Publication date:
February 20, 2014
Applicant:
Monash University
Inventors:
David Morton, Laurence Orlando, Tony Q. Zhou, Louise C. Ho
Abstract: The present invention relates to a catalyst comprising (i) a semiconductor preferably comprising one or more metal-(Group VIb) semiconductors, and (ii) a semiconductor material having elevated phosphorous content preferably comprising one or more metal-(Group VIb))-phosphorous species
Type:
Application
Filed:
March 22, 2012
Publication date:
February 6, 2014
Applicant:
MONASH UNIVERSITY
Inventors:
Douglas Macfarlane, Bjorn Winther-Jensen, Alexey Izgorodin
Abstract: The present invention relates to a controlled metathesis-driven polymerization process which is particularly useful for the synthesis of biological polymers such as peptides and polymers. The invention also provides metathesisable supports, groups and linkers for use in the process.
Abstract: An organic cation for a battery, including a heteroatom-containing cyclic compound having at least (2) ring structures formed from rings that share at least one common atom, the cyclic compound having both a formal positive charge of at least +1 and a partial negative charge.
Type:
Application
Filed:
March 18, 2011
Publication date:
August 8, 2013
Applicants:
MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Inventors:
George Hamilton Lane, Adam Samuel Best, Anand I. Bhatt, Youssof Shekibi, Bronya R. Clare
Abstract: The invention relates to the finding that T cell protein tyrosine phosphatase (TCPTP) has a tumour suppressor function. In one particular application, the invention provides a method of diagnosis and/or prognosis of cancer in a subject involving the assessment, in a suitable body sample, of any lack or reduction of TCPTP protein and/or Ptpn2 gene expression. The invention also provides a method of treating or preventing cancer in a subject involving administering to a subject an agent for modulating the activity of TCPTP.
Type:
Application
Filed:
February 3, 2011
Publication date:
August 8, 2013
Applicant:
MONASH UNIVERSITY
Inventors:
Tony Tiganis, Benjamin James Shields, Catriona Ann McLean, Robert Sutherland
Abstract: A gel film or an isolated gel film comprising sheets of graphene or chemically converted graphene at least partially separated by a dispersion medium, such as water, and arranged in a substantially planar manner to form an electrically conductive matrix.
Abstract: A crystal comprising an isoform of an N-terminally truncated glutamic acid decarboxylase (GAD) chosen from the group consisting of a monoclinic P21 space group with unit cell dimensions of a =84.05±2.3 ?, b=62.74±2.3 ?, c=101.35±2.3 ? and ? =106.69° (GAD67) or an orthorhombic C2221 space group with unit cell dimensions of a=78.25±2.3 ?, b=99.05±2.3 ? and c=120.01±2.3 ?(GAD65).
Type:
Grant
Filed:
September 13, 2007
Date of Patent:
April 16, 2013
Assignee:
Monash University
Inventors:
James Charles Whisstock, Ashley Maurice Buckle, Gustavo Fenalti, Ruby Hong Ping Law, Merrill Joy Rowley
Abstract: A 2D or 3D velocity field is reconstructed from a cross-correlation analysis of image pairs of a sample, without first reconstructing images of the sample spatial structure. The method can be implemented via computer tomographic x-ray particle image velocimetry, using multiple projection angles, with phase contrast images forming dynamic speckle patterns. Estimated cross-correlations may be generated via convolution of a measured autocorrelation function with a velocity probability density function, and the velocity coefficients iteratively optimised to minimise the error between the estimated cross-correlations and the measured cross-correlations. The method may be applied to measure blood flow, and the motion of tissue and organs such as heart and lungs.
Abstract: A testing device for identifying an antigen or antibody within a biofluid sample including: a substrate having a hydrophilic surface thereon; the surface including a collection zone, and at least one detection zone extending therefrom; wherein the biofluid sample can be mixed with a specific antigen or antibody, and deposited on the collection zone and transferred by capillary action to the detection zone; the antigen or antibody in the biofluid sample reacting with an appropriate said antibody or antigen thereby resulting in a visual indication within the detection zone.
Type:
Application
Filed:
September 24, 2010
Publication date:
December 20, 2012
Applicant:
Monash University
Inventors:
Gil Garnier, Wei Shen, Mohidus Samad Khan, Xu Li, George Thouas
Abstract: The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof.
Abstract: The invention relates to methods and compositions for reducing blood glucose levels in hyperglycaemic subjects. The methods and compositions may therefore be suitable for treating a disease or condition associated with hyperglycaemia such as, for example, obesity (particularly diet induced obesity (DIO)), weight gain, Type II diabetes mellitus, insulin sensitivity, impaired glucose tolerance and inflammation. In some embodiments, the methods comprise administering a melanocortin-5 receptor (MC5R) agonist to one or more skeletal muscle cells of the subject. Preferred MC5R agonists are those that specifically activate MC5R and/or enhance expression of MC5R, such as the melanocortin analogue, Ac-Nle-c[Asp-Pro-D-Nal(2?)-Arg-Trp-Lys]-NH2.
Type:
Application
Filed:
January 25, 2011
Publication date:
December 6, 2012
Applicant:
Monash University
Inventors:
Michael Alexander Cowley, Pablo Jose Enriori, Russell Deputy Brown, Iain James Clarke, Belinda Anne Henry, Maria Cecilia Garcia-Rudaz
Abstract: Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.
Type:
Application
Filed:
September 28, 2010
Publication date:
November 29, 2012
Applicants:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, MONASH UNIVERSITY, CLAYTON, GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO, S.L, UNIVERSITY OF WASHINGTON, MEDICINES FOR MALARIA VENTURE
Inventors:
Pradipsinh K. Rathod, David Floyd, Jeremy Burrows, Alka Marwaha, Ramesh Gujjar, Jose Coteron-Lopez, Margaret Phillips, Susan A. Charman, David Matthews
Abstract: A navigable system for catheter based endovascular neurosurgery including: a micro-motor (3) including a piezoelectric actuator (5) mounted to a free end of a guidewire or micro-catheter (2), the piezoelectric actuator (5) including a piezoelectric element (7), and an elongate transducer (9) mounted on the piezoelectric element (7) and extending therefrom, the transducer (9) being formed from an asymmetric hollow member, and an end member (15) located at a free end of the transducer (9); wherein electrical excitation of the piezoelectric element (7) induces one or both orthogonal flexural and axial vibration modes within the transducer (9), the coupling of the induced vibration modes thereby resulting in rotation of the end member (15) with three degrees of freedom (DOF).